Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

Theresa A. Zesiewicz; Kelly L. Sullivan; A. Miller; L. E. Dempsey; Israt Jahan; L. Wecker

Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

Theresa A. Zesiewicz, Kelly L. Sullivan, A. Miller, L. E. Dempsey, Israt Jahan, L. Wecker

Biostatistics, Epidemiology, & Environmental Health Sciences

University of South Florida

Research output: Contribution to conference › Presentation

Abstract

This presentation was given at the World Congress on Parkinson’s Disease and Related Disorders.

Original language	American English
State	Published - Dec 13 2009
Event	World Congress on Parkinson’s Disease and Related Disorders - Miami Beach, FL Duration: Dec 13 2009 → …

Conference

Conference	World Congress on Parkinson’s Disease and Related Disorders
Period	12/13/09 → …

Keywords

Ataxic patients
Chantix
Drug discontinuation
Long-term effect
Prolonged symptomatic benefit
Varenicline

DC Disciplines

Public Health
Epidemiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{3e3c359a757a424c874bbefca09ca7c0,

title = "Long-Term Effect of Varenicline (Chantix{\textregistered}) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation",

abstract = " This presentation was given at the World Congress on Parkinson{\textquoteright}s Disease and Related Disorders.",

keywords = "Ataxic patients, Chantix, Drug discontinuation, Long-term effect, Prolonged symptomatic benefit, Varenicline",

author = "Zesiewicz, {Theresa A.} and Sullivan, {Kelly L.} and A. Miller and Dempsey, {L. E.} and Israt Jahan and L. Wecker",

year = "2009",

month = dec,

day = "13",

language = "American English",

note = "World Congress on Parkinson{\textquoteright}s Disease and Related Disorders ; Conference date: 13-12-2009",

}

TY - CONF

T1 - Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

AU - Zesiewicz, Theresa A.

AU - Sullivan, Kelly L.

AU - Miller, A.

AU - Dempsey, L. E.

AU - Jahan, Israt

AU - Wecker, L.

PY - 2009/12/13

Y1 - 2009/12/13

N2 - This presentation was given at the World Congress on Parkinson’s Disease and Related Disorders.

AB - This presentation was given at the World Congress on Parkinson’s Disease and Related Disorders.

KW - Ataxic patients

KW - Chantix

KW - Drug discontinuation

KW - Long-term effect

KW - Prolonged symptomatic benefit

KW - Varenicline

M3 - Presentation

T2 - World Congress on Parkinson’s Disease and Related Disorders

Y2 - 13 December 2009

ER -

Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

Abstract

Conference

Keywords

DC Disciplines

UN SDGs

Fingerprint

Cite this